Biotech Values

[jq1234]

THRX: I have to correct myself here. The remaining THRX would hold more respiratory assets than I initially thought after further examination. They not only hold their own LAMA program TD4208, but also those MABA programs partnered with GSK. So it is still attractive hold IMO.